Skip to main content
Figure 1 | Journal of Translational Medicine

Figure 1

From: Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation

Figure 1

B cell CD86 expression in response to titrated amounts of the CD40 mAb CP-870,893. CD19+ B cells were purified from PBMC by negative selection and stimulated in the presence of hIgG2 or the indicated concentrations of CP-870,893 mAb. Cell surface CD86 expression was measured as mean fluorescence intensity pre-stimulation and at 24 hr and 48 hr after stimulation using flow cytometry. Results shown are for one donor and representative of three evaluated.

Back to article page